Pharmacology and Toxicology

  1. Methylene Blue Inhibits the SARS-CoV-2 Spike–ACE2 Protein-Protein Interaction–a Mechanism that can Contribute to its Antiviral Activity Against COVID-19

    1. Damir Bojadzic
    2. Oscar Alcazar
    3. Peter Buchwald

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. First-described recently discovered non-toxic vegetal-derived furocoumarin preclinical efficacy against SARS-CoV-2: a promising antiviral herbal drug

    1. Iván José Galindo-Cardiel
    2. Adriana Toledo Núñez
    3. María Celaya Fernández
    4. Ariel Ramírez Labrada
    5. Iratxe Uranga-Murillo
    6. Maykel Arias Cabrero
    7. Julian Pardo
    8. Ezio Panzeri

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Rejuveinix Mitigates Sepsis-Associated Oxidative Stress in the Brain of Mice: Clinical Impact Potential in COVID-19 and Nervous System Disorders

    1. Fatih M. Uckun
    2. Mehmet Tuzcu
    3. Marcus Gitterle
    4. Michael Volk
    5. Kazim Sahin

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. A phenomics approach for in vitro antiviral drug discovery

    1. Jonne Rietdijk
    2. Marianna Tampere
    3. Aleksandra Pettke
    4. Polina Georgieva
    5. Maris Lapins
    6. Ulrika Warpman Berglund
    7. Ola Spjuth
    8. Marjo-Riitta Puumalainen
    9. Jordi Carreras-Puigvert

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Drug synergy of combinatory treatment with remdesivir and the repurposed drugs fluoxetine and itraconazole effectively impairs SARS-CoV-2 infection in vitro

    1. Sebastian Schloer
    2. Linda Brunotte
    3. Angeles Mecate-Zambrano
    4. Shuyu Zheng
    5. Jing Tang
    6. Stephan Ludwig
    7. Ursula Rescher

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Development of a highly sensitive bioanalytical assay for the quantification of favipiravir

    1. Paul Curley
    2. Megan Neary
    3. Usman Arshad
    4. Lee Tatham
    5. Henry Pertinez
    6. Helen Box
    7. Rajith KR Rajoli
    8. Anthony Valentijn
    9. Joanne Sharp
    10. Steve P Rannard
    11. Andrew Owen

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Hydroxychloroquine Proves Ineffective in Hamsters and Macaques Infected with SARS-CoV-2

    1. Kyle Rosenke
    2. Michael A. Jarvis
    3. Friederike Feldmann
    4. Benjamin Schwarz
    5. Atsushi Okumura
    6. Jamie Lovaglio
    7. Greg Saturday
    8. Patrick W. Hanley
    9. Kimberly Meade-White
    10. Brandi N. Williamson
    11. Frederick Hansen
    12. Lizette Perez-Perez
    13. Shanna Leventhal
    14. Tsing-Lee Tang-Huau
    15. Martha Nason
    16. Julie Callison
    17. Elaine Haddock
    18. Dana Scott
    19. Graham Sewell
    20. Catharine M. Bosio
    21. David Hawman
    22. Emmie de Wit
    23. Heinz Feldmann

    Reviewed by ScreenIT

    2 evaluationsAppears in 1 listLatest version Latest activity

  8. The SARS-CoV-2 replication-transcription complex is a priority target for broad-spectrum pan-coronavirus drugs

    1. Setayesh Yazdani
    2. Nicola De Maio
    3. Yining Ding
    4. Vijay Shahani
    5. Nick Goldman
    6. Matthieu Schapira

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. In vitro efficacy of Artemisia extracts against SARS-CoV-2

    1. Chuanxiong Nie
    2. Jakob Trimpert
    3. Sooyeon Moon
    4. Rainer Haag
    5. Kerry Gilmore
    6. Benedikt B. Kaufer
    7. Peter H. Seeberger

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Development of Remdesivir as a Dry Powder for Inhalation by Thin Film Freezing

    1. Sawittree Sahakijpijarn
    2. Chaeho Moon
    3. John J. Koleng
    4. Dale J. Christensen
    5. Robert O. Williams

    Reviewed by ScreenIT

    3 evaluationsAppears in 1 listLatest version Latest activity
Previous Page 17 of 22 Next